Pfizer's new and recently acquired products generated 22% operational growth in Q1. The company faces a challenging road ...

A few years ago, Pfizer (PFE +0.51%) looked unstoppable. The company generated more than $100 billion in annual revenue early ...

Arvinas and Pfizer to receive $85 million in upfront and transition payments with potential for additional $320 million in development, ...

Pfizer is looking to newer products and acquisitions to offset a declining Covid business.

Thus, the incentive for income investors to buy Pfizer stock is high. But others will argue that so too is the risk. And ...

Rigel Pharmaceuticals said on Tuesday it has struck a global licensing deal for Arvinas and Pfizer's recently ​approved breast cancer drug, marking Rigel's fourth ‌commercial product on the market.

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.

Pfizer has won expanded European Commission approval of its Hympavzi hemophilia drug for two patient populations. Pfizer on Wednesday said the green light covers patients ages 12 and older weighing at ...

Arvinas and Pfizer have chosen Rigel Pharmaceuticals to bring their recently approved breast-cancer drug Veppanu to market.

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 8:00 a.m. EST on Tuesday, ...

Those eager to discredit Pfizer's mRNA vaccine, which is safe and effective, exploited the cruise ship outbreak.

Dec 10 (Reuters) - Pfizer will ‌cut over 200 jobs ‌in Switzerland as part of its multi-year cost reduction program, Bloomberg News reported on ‍Wednesday, citing people familiar with the matter. The ...